|Source:||The leaves of Camellia sinensis|
|Biological Activity or Inhibitors:|| 1. (-)-Epigallocatechin-3-(3''-O-methyl)gallate shows a strong antioxidative activity, it also has a strong cytotoxic activity.
2. (-)-Epigallocatechin-3-O-(3-O-methyl)-gallate has potent antiallergic activity, it can negatively regulate basophil activation through the suppression of FcepsilonRI expression.
3. (-)-Epicatechin 3-(3-O-methylgallate) has anti-inflammatory effect, it can suppress the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation of mouse ears, its activity is stronger than those of indomethacin and glycyrrhetinic acid, the normally used anti-inflammatory agents.
4. Epigallocatechin-3-(3''-O-methyl)gallate has the function for cold preservation of primary rat hepatocytes.
|Solvent:||Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.|
|Storage:||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
|After receiving:||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.|
|1 mg||5 mg||10 mg||20 mg||25 mg|
|1 mM||2.1169 mL||10.5843 mL||21.1685 mL||42.337 mL||52.9213 mL|
|5 mM||0.4234 mL||2.1169 mL||4.2337 mL||8.4674 mL||10.5843 mL|
|10 mM||0.2117 mL||1.0584 mL||2.1169 mL||4.2337 mL||5.2921 mL|
|50 mM||0.0423 mL||0.2117 mL||0.4234 mL||0.8467 mL||1.0584 mL|
|100 mM||0.0212 mL||0.1058 mL||0.2117 mL||0.4234 mL||0.5292 mL|
Agr. Biol. Chem., 2000, 64(10):2218-20.
|Antioxidative activity of (-)-epigallocatechin-3-(3''-O-methyl)gallate isolated from fresh tea leaf and preliminary results on its biological activity.[Pubmed: 11129598 ]|
|Antioxidative activity of (-)-Epigallocatechin-3-(3''-O-methyl) gallate (catechine) was examined. Catechin e showed a strong antioxidative activity. A preliminary test using rat cancer cells suggests that catechin e also has a strong cytotoxic activity. Among tested catechins, only catechin e has strong activity for both.|
J. Agr. Food Chem., 2002, 50(20):5729-34.
|Antiallergic tea catechin, (-)-epigallocatechin-3-O-(3-O-methyl)-gallate, suppresses FcepsilonRI expression in human basophilic KU812 cells.[Pubmed: 12236706]|
|We previously found that the O-methylated derivative of (-)-Epigallocatechin-3-O-gallate (EGCg), (-)-epigallocatechin-3-O-(3-O-methyl)-gallate (EGCG' '3Me), has potent antiallergic activity. The high-affinity IgE receptor, FcepsilonRI, is found at high levels on basophils and mast cells and plays a key role in a series of acute and chronic human allergic reactions. To understand the mechanism of action for the antiallergic EGCG' '3Me, the effect of EGCG' '3Me on the cell surface expression of FcepsilonRI in human basophilic KU812 cells was examined. Flow cytometric analysis showed that EGCG' '3Me was able to decrease the cell surface expression of FcepsilonRI. Moreover, immunoblot analysis revealed that total cellular expression of the FcepsilonRI alpha chain decreased upon treatment with EGCG' '3Me. FcepsilonRI is a tetrameric structure comprising one alpha chain, one beta chain, and two gamma chains. The level of mRNA production of each subunit in KU812 cells was investigated. EGCG' '3Me reduced FcepsilonRI alpha and gamma mRNA levels. The cross-linkage of FcepsilonRI causes the activation of basophils, which leads to the secretion of inflammatory mediators including histamine. EGCG' '3Me treatment inhibited the FcepsilonRI cross-linking-induced histamine release. These results suggested that EGCG' '3Me can negatively regulate basophil activation through the suppression of FcepsilonRI expression.|